PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 68 filers reported holding PREVAIL THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $159,000 | – | 13,054 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 13,822,463 | $205,955,000 | 2.90% |
| Avidity Partners Management LP | 1,028,800 | $15,329,000 | 0.98% |
| Omega Fund Management, LLC | 187,538 | $2,794,000 | 0.76% |
| Boxer Capital, LLC | 1,123,105 | $16,734,000 | 0.74% |
| RA Capital Management | 2,494,691 | $37,171,000 | 0.72% |
| EcoR1 Capital, LLC | 367,218 | $5,472,000 | 0.40% |
| QVT Financial LP | 133,690 | $1,992,000 | 0.34% |
| DAFNA Capital Management LLC | 75,000 | $1,118,000 | 0.32% |
| Woodline Partners LP | 329,135 | $4,904,000 | 0.19% |
| Virtus ETF Advisers LLC | 22,460 | $335,000 | 0.16% |